ERBA Diagnostics, Inc., a fully integrated in vitro diagnostics company, has
announcedits first quarter results for the FY-2015.
The results shows Revenues of $4.85 Million down by -23.9% YoY, while EPS was -$0.02 down by -$0.02.
Quarterly Fiscal Highlights:
The firm recorded Revenue of $4.9 Million previous was $6.4 Million
Net Loss of $1.0 Million last year it was Net Income of $0.2 Million
Gross margin Down to 43% from 46%
View the full earnings release here.